OLMA•benzinga•
Olema Oncology To Present Preclinical Data For OP-3136, A Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity In Multiple Solid Tumor Models At The 2025 AACR Annual Meeting
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 25, 2025 by benzinga